Veralto CapEx decreased by 40.0% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.0%, from $15.00M to $12.00M. Over 3 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 5.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.50M | $13.50M | $13.50M | $8.00M | $9.00M | $12.00M | $11.00M | $22.00M | $13.00M | $11.00M | $9.00M | $22.00M | $15.00M | $16.00M | $12.00M | $20.00M | $12.00M |
| QoQ Change | — | +0.0% | +0.0% | -40.7% | +12.5% | +33.3% | -8.3% | +100.0% | -40.9% | -15.4% | -18.2% | +144.4% | -31.8% | +6.7% | -25.0% | +66.7% | -40.0% |
| YoY Change | — | — | — | -40.7% | — | — | — | +175.0% | +44.4% | -8.3% | -18.2% | +0.0% | +15.4% | +45.5% | +33.3% | -9.1% | -20.0% |